![Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection - European Urology Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/169d2b4a-1f53-4c42-afe9-718692dcf82c/gr1.jpg)
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection - European Urology
![PDF) Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application PDF) Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application](https://i1.rgstatic.net/publication/328770510_Levosimendan_in_Acute_and_Advanced_Heart_Failure_an_Expert_Perspective_on_Posology_and_Therapeutic_Application/links/5fbcfee4299bf104cf6f777d/largepreview.png)
PDF) Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
![TCT-474 FANTOM II Long Lesion Study: Initial Safety and Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions—First Report: 2-Year Outcomes | Journal of the American College of Cardiology TCT-474 FANTOM II Long Lesion Study: Initial Safety and Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions—First Report: 2-Year Outcomes | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/6585107f-954d-4641-b6e6-9bb4ea022338/j.jacc.2021.09.1327.fp.png)
TCT-474 FANTOM II Long Lesion Study: Initial Safety and Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions—First Report: 2-Year Outcomes | Journal of the American College of Cardiology
![Plasmatic Exosome Number and Size Distinguish Prostate Cancer Patients From Healthy Individuals: A Prospective Clinical Study | Oncology - Frontiers Plasmatic Exosome Number and Size Distinguish Prostate Cancer Patients From Healthy Individuals: A Prospective Clinical Study | Oncology - Frontiers](https://www.frontiersin.org/files/MyHome%20Article%20Library/727317/727317_Thumb_400.jpg)
Plasmatic Exosome Number and Size Distinguish Prostate Cancer Patients From Healthy Individuals: A Prospective Clinical Study | Oncology - Frontiers
![PDF) Extracorporeal shock-wave therapy for supraspinatus calcifying tendinitis: a randomized clinical trial comparing two different energy levels | Angelo Cacchio - Academia.edu PDF) Extracorporeal shock-wave therapy for supraspinatus calcifying tendinitis: a randomized clinical trial comparing two different energy levels | Angelo Cacchio - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/50189910/mini_magick20190129-31835-7r2dsq.png?1548807514)
PDF) Extracorporeal shock-wave therapy for supraspinatus calcifying tendinitis: a randomized clinical trial comparing two different energy levels | Angelo Cacchio - Academia.edu
![A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study | British Journal of Cancer A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6602241/MediaObjects/41416_2004_Article_BF6602241_Fig1_HTML.gif)
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study | British Journal of Cancer
![Infrarenal Abdominal Aortic Aneurysm Endovascular Treatment: Long-term Results From a Single-Center Experience in an Unselected Patient Population - Annals of Vascular Surgery Infrarenal Abdominal Aortic Aneurysm Endovascular Treatment: Long-term Results From a Single-Center Experience in an Unselected Patient Population - Annals of Vascular Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/7e6907f9-0727-416f-ae9d-f0b7e3b5368d/gr1.jpg)
Infrarenal Abdominal Aortic Aneurysm Endovascular Treatment: Long-term Results From a Single-Center Experience in an Unselected Patient Population - Annals of Vascular Surgery
![Five year clinical follow-up of the PASSION-trial Five year clinical follow-up of the PASSION-trial Five Year Follow-up after Primary PCI with a Paclitaxel-Eluting. - ppt download Five year clinical follow-up of the PASSION-trial Five year clinical follow-up of the PASSION-trial Five Year Follow-up after Primary PCI with a Paclitaxel-Eluting. - ppt download](https://slideplayer.com/1/527191/big_thumb.jpg)
Five year clinical follow-up of the PASSION-trial Five year clinical follow-up of the PASSION-trial Five Year Follow-up after Primary PCI with a Paclitaxel-Eluting. - ppt download
![Il Clinical Trial Center del Gemelli illustra i percorsi della ricerca ai Pazienti Esperti - Policlinico Universitario A. Gemelli IRCCS Il Clinical Trial Center del Gemelli illustra i percorsi della ricerca ai Pazienti Esperti - Policlinico Universitario A. Gemelli IRCCS](https://www.policlinicogemelli.it/wp-content/uploads-shared/2022/01/screenEupati_news.jpg)
Il Clinical Trial Center del Gemelli illustra i percorsi della ricerca ai Pazienti Esperti - Policlinico Universitario A. Gemelli IRCCS
![Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology | Scientific Reports Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-03204-z/MediaObjects/41598_2021_3204_Fig1_HTML.png)
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology | Scientific Reports
![Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies - Journal of Allergy and Clinical Immunology Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bb1c35eb-e1aa-45b8-a000-40a3f99c2e59/fx1.jpg)
Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies - Journal of Allergy and Clinical Immunology
![PDF) Evolution of Clinical Trials in Ovarian Cancer Management over the Past 20 Years: Never Settle Down, Always Go Beyond PDF) Evolution of Clinical Trials in Ovarian Cancer Management over the Past 20 Years: Never Settle Down, Always Go Beyond](https://i1.rgstatic.net/publication/355139239_Evolution_of_Clinical_Trials_in_Ovarian_Cancer_Management_over_the_Past_20_Years_Never_Settle_Down_Always_Go_Beyond/links/615fa0f71eb5da761e5dfc84/largepreview.png)
PDF) Evolution of Clinical Trials in Ovarian Cancer Management over the Past 20 Years: Never Settle Down, Always Go Beyond
![Come migliorare la ricerca clinica: l'epoca del fare. Resoconto dell'evento annuale di AICRO - Seconda parte | CRAsecrets.com Come migliorare la ricerca clinica: l'epoca del fare. Resoconto dell'evento annuale di AICRO - Seconda parte | CRAsecrets.com](https://i0.wp.com/crasecrets.com/wp-content/uploads/2017/12/working-group-300x199.png?resize=300%2C199)